Tag: malignant neoplasia

When treating early-stage breast cancer, decisions made on age alone can miss the mark, say researchers reporting new data showing ...

The study covered in this summary was published on ResearchSquare.com as a preprint and has not yet been peer reviewed. ...

Nearly half of all deaths from cancer are caused by known modifiable risk factors, with smoking, alcohol consumption, and high ...

Dexrazoxane (Totect, Zinecard) provides long-term cardioprotection for children treated with doxorubicin for cancer, and its co-administration with doxorubicin should be ...

The US Food and Drug Administration (FDA) has granted accelerated approval to pirtobrutinib (Jaypirca) for relapsed or refractory mantle cell ...

The US Food and Drug Administration approved elacestrant (Orserdu, Stemline Therapeutics, Inc) for postmenopausal women or men with ER-positive, HER2-negative, ...

SAN FRANCISCO — Adding stereotactic body radiation therapy (SBRT) to sorafenib produced better outcomes among patients with hepatocellular carcinoma (HCC) ...

Starting colorectal cancer screening earlier than age 50 appears to be cost-effective for both men and women across all body ...

(Reuters) - Pfizer Inc is exploring options for some early-stage treatments for rare diseases and cancer in a bid to ...

Direct oral anticoagulants (DOACs) are more clinically effective and are more cost-effective for treating patients with cancer-associated thrombosis (CAT) in ...